1. Home
  2. WB vs IDYA Comparison

WB vs IDYA Comparison

Compare WB & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weibo Corporation

WB

Weibo Corporation

HOLD

Current Price

$9.99

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$30.96

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WB
IDYA
Founded
2009
2015
Country
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WB
IDYA
Price
$9.99
$30.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
15
Target Price
$14.00
$49.85
AVG Volume (30 Days)
1.0M
800.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
16.48%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.53
N/A
Revenue Next Year
$2.38
$97.58
P/E Ratio
$5.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.10
$13.45
52 Week High
$12.96
$39.28

Technical Indicators

Market Signals
Indicator
WB
IDYA
Relative Strength Index (RSI) 39.72 38.70
Support Level $9.70 $29.47
Resistance Level $10.37 $33.63
Average True Range (ATR) 0.30 1.60
MACD -0.06 -0.27
Stochastic Oscillator 20.80 27.58

Price Performance

Historical Comparison
WB
IDYA

About WB Weibo Corporation

Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: